Mining
Talga secures Japanese patent for advanced graphite anodes
Talga Group (ASX:TLG) has secured a Japanese patent for its advanced natural graphite anode technology.
Isaac Francis
Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Articles by Isaac Francis
Technology
ClearSign shares surge as preliminary Q4 revenue skyrockets 510%
ClearSign Technologies Corporation (NASDAQ:CLIR) provided preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025, showing substantial revenue growth.
Advertising and Marketing
Super League acquires Let’s Bounce to enhance in-game brand engagement capabilities
Super League Enterprise (NASDAQ:SLE) announced on January 7, 2026, the acquisition of Let’s Bounce (Bounce), a marketing-technology company specializing in scalable brand engagement within gaming and user-generated content (UGC) environments.
Transport and logistics
Alaska Airlines places landmark 110-jet order to fuel global expansion
Alaska Airlines (NYSE:ALK) revealed on January 7, 2026, its largest aircraft order in company history, committing to purchase 105 Boeing 737 MAX 10 jets and five Boeing 787-10 Dreamliners.
Media
Warner Bros. Discovery board unanimously recommends rejection of Paramount-Skydance amended offer
Warner Bros. Discovery (NASDAQ:WBD) announced that its Board of Directors has unanimously recommended that shareholders reject the amended tender offer from Paramount Skydance (PSKY) and continue to support the pending merger with Netflix (NASDAQ:NFLX).
Health
Arrowhead Pharmaceuticals Secures Chinese Approval for REDEMPLO in Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals (NASDAQ:ARWR) today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult patients with familial chylomicronemia syndrome (FCS).
Health
Compass Pathways advances COMP360 into late-stage PTSD trials
Compass Pathways (NASDAQ:CMPS) reached a pivotal milestone on Wednesday, January 7, 2026, as the U.S. FDA accepted the company’s Investigational New Drug (IND) application for COMP360, its proprietary synthetic psilocybin treatment, for the treatment of Post-Traumatic Stress Disorder (PTSD).
Technology
Infosys and Cognition partner to deploy "Devin" AI software engineer globally
Infosys (NYSE:INFY) and Cognition announced a strategic collaboration on January 7, 2026, to scale Devin, the world’s first autonomous AI software engineer, across Infosys’ vast global operations.
Health
GSK and Ionis break new ground in Hepatitis B with positive Phase 3 results
Ionis Pharmaceuticals (NASDAQ:IONS) shares hovered near 52-week highs Wednesday after partner GSK (NYSE:GSK) announced that its experimental drug, bepirovirsen, successfully met the primary endpoints in two pivotal Phase 3 trials, B-Well 1 and B-Well 2.
-640x358.jpg&w=3840&q=75)
Wealth transfer could accelerate crypto adoption industry says
A generational wealth shift could drive wider crypto adoption as younger, tech-savvy investors gain control of assets.